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The kinetics of cholesterol extraction from cellular membranes is complex and not yet completely understood. In this paper we have developed
an experimental approach to directly monitor the extraction of cholesterol from lipid membranes by using surface plasmon resonance and model
lipid systems. Methyl-β-cyclodextrin was used to selectively remove cholesterol from large unilamellar vesicles of various compositions. The
amount of extracted cholesterol is highly dependent on the composition of lipid membrane, i.e. the presence of sphingomyelin drastically reduced
and slowed down cholesterol extraction by methyl-β-cyclodextrin. This was confirmed also in the erythrocyte ghosts system, where more
cholesterol was extracted after erythrocytes were treated with sphingomyelinase. We further show that the kinetics of the extraction is mono-
exponential for mixtures of 1,2-dioleoyl-sn-glycero-3-phosphocholine and cholesterol. The kinetics is complex for ternary lipid mixtures
composed of 1,2-dioleoyl-sn-glycero-3-phosphocholine, bovine brain sphingomyelin and cholesterol. Our results indicate that the complex
kinetics observed in experiments with cells may be the consequence of lateral segregation of lipids in cell plasma membrane.
© 2007 Elsevier B.V. All rights reserved.Keywords: Lipid membrane; Cholesterol extraction; Cyclodextrin; Surface plasmon resonance; Biacore1. Introduction
Cyclodextrins (CDs) are a family of cyclic oligomers of
glucose, linked by α-1,4 glycosidic bonds. They differ in the
number of glucose units in the ring, i.e. they are composed of
six, seven or eight glucose units in α-, β- or γ-CD,
respectively [1]. They are highly hydrophilic molecules
with a hydrophobic core in which they can bind and thereby
solubilize hydrophobic molecules [2,3]. Derivatives of CDs,
which are more soluble and less toxic [2], have been in use in
pharmacological research for years as carriers of lipophilic
drugs and only in last two decades has their use in membraneAbbreviations: CHO, cholesterol; CD, cyclodextrin; DOPC, 1,2-Dioleoyl-
sn-Glycero-3-Phosphocholine; LUV, large unilamellar vesicles; MBCD,
methyl-β-cyclodextrin; NBD-CHO, 25-(N-[(7-nitrobenz-2-oxa-1,3-diazol-4-
yl)-methyl]amino)-27-norcholesterol; RU, response units; SM, sphingomyelin;
SPR, surface plasmon resonance
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doi:10.1016/j.bbamem.2007.09.022studies been appreciated [4]. In the latter they are mostly used
in studies of cholesterol (CHO) role in the cellular
membranes [4–8]. β-CD and its derivatives, methyl-β-CD
(MBCD) and 2-hydoxypropyl-β-CD, are mostly chosen for
these studies as they extract membrane CHO very efficiently
[4,5,8,9]. MBCD is CHO-specific at concentrations below
10 mM and only negligibly binds other lipids [10,11]. At low
concentrations (b1 mM) it has also been used as a catalyst
for CHO transfer between lipid membranes and other CHO
acceptors, such as serum lipoproteins [6,9], or for inter-
vesicular CHO transfer [10].
The mechanism of CHO extraction by CD is not yet fully
understood. In CHO extraction experiments most authors have
observed neither significant binding to nor inserting into the
membranes of the extracting agent [1,4]. It was hypothesized
that CHO efflux from the membranes occurs primarily by an
aqueous diffusion mechanism in which CHO molecules desorb
from the cell or vesicular membrane and are incorporated in
either lipoprotein or MBCD molecule after diffusion across
aqueous layer [4]. The reason for much faster process mediated
by CDs compared to serum lipoproteins might be much smaller
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to the cellular membrane and/or reversible CD–membrane in-
teractions [4,9,12]. This hypothesis has been contradicted by
Steck and co-workers [8], whose results indicate the extraction
proceeds via activation–collision pathway so that lipid mono-
mers enter an activated state, e.g. partial projection from the lipid
bilayer, and from this state they are either captured by collision
with acceptors or return to the ground state [8,13]. The stoichi-
ometry of the complex has been estimated to be 1:1 [14] but
more recently the stoichiometry of 2:1 was suggested [11].
These are corroborated bymolecular dimensions of both species,
i.e. the CHO molecule is ∼18 Å long, whereas the length of
MBCD hydrophobic cavity is only ∼8 Å [11].
Most of the literature suggests that there are »two pools« of
CHO in cellular and lipid vesicle membranes [4,5,15–18]. On the
basis of the kinetics of CHO extraction by CD, a fast and a slow
CHO pools with half times of approximately half a minute and
10 min to half hour, respectively, were observed [4,5,17,18]. The
two CHO pools have also been observed in vesicles composed of
dipalmitoyl-glycero-phosphocholine, palmitoyl-oleoyl-glycero-
phosphoglycerol and CHO [5]. While the fast pool is most likely
the CHO present in plasma membrane, the slow pool might be
attributed to intracellular CHO, CHO present in the intracellular
monolayer of the plasma membrane or CHO in a separate lateral
domain in the plasma membrane [5]. This has not yet been
satisfactorily resolved, but studies in recent years indicated that
the latter possibility is actually the most likely. The CHO efflux
from cellular and model membranes is slower, if there is
sphingomyelin (SM) present in the membrane [19–21]. It has
been also shown that the sphingomyelinase treatment of cell
membranes drastically increases CHO efflux from membranes
[17,22], whereas there is no such effectwhen phosphatidylcholine
content is changed [22]. The same phenomenon was shown to
hold true for lipid monolayers, further confirming the cholesterol
desorption experiments from bilayers [23] and implies that
cholesterol preferentially associates with SM [24,25].
Most of the experimental procedures, which are also time and
material consuming, for monitoring the extraction of cholesterol
require radioactive labeling of cholesterol in cellular or vesicular
membranes [4,5,8,17,18,26] and/or CD molecules [5]. One
exception is very recent experimental work in which isothermal
titration calorimetry was employed, which is fast and does not
require radioactive labeling of the molecules [11,27]. Here, we
have employed a surface plasmon resonance (SPR) approach,
which allows direct monitoring of the extraction process, to
address the question of kinetics of CHO extraction from mem-
branes of different compositions. SPR on a Biacore technology
is mainly used in biochemistry to study kinetics of molecular
interactions, such as protein–protein, protein–small molecule,
protein–membrane, etc. The most obvious advantages of SPR
over other techniques are direct and rapid determination of
association and dissociation rates of binding process, no need for
labeling of molecules, and low amount of sample that is used in
an assay [28–31]. It is possible to immobilize intact liposomes
on the L1 Biacore sensor chip, which has covalently linked
lipophilic anchors on a dextran matrix [32,33]. Liposomes are
stably retained on this surface, when low flow-rates are applied.It is, therefore, easy to reproducibly prepare stable liposome
surface under various experimental conditions, i.e. lipid com-
position, temperature or pH. So, in a typical experiment, a
liposome surface is prepared on the surface of the sensor chip
and the molecule of interest is passed over.
In thisworkwe introduced and optimized the SPR technique to
monitor real-time kinetics of CHO desorption from lipid vesicles
using MBCD. We show that MBCD does not bind to dioleoyl-
glycero-phosphocholine (DOPC) membranes and does not per-
turb lipid membranes. The extraction by MBCD is CHO-specific
in the concentrations below 2 mM. It is highly dependent on the
composition of lipid membrane, i.e. the presence of sphingo-
myelin drastically slowed down cholesterol extraction byMBCD.
We finally show that the kinetics of the extraction is complex for
ternary lipid mixtures composed of DOPC, SM and CHO.
2. Materials and methods
2.1. Materials
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), bovine brain sphingo-
myelin (SM), cholesterol (CHO), and 25-{N-[(7-nitrobenz-2-oxa-1,3-diazol-4-
yl)-methyl]amino}-27-norcholesterol (NBD-CHO) were obtained from Avanti
Polar Lipids (USA). Methyl-β-cyclodextrin (MBCD), Triton X-100, streptoly-
sin and Bacillus cereus sphingomyelinase were from Sigma. Throughout this
work a following SPR buffer was used: 140 mMNaCl, 20 mMNaH2PO4, 1 mM
EDTA, pH 7.5.
2.2. Large unilamellar vesicles preparation and characterization
The lipids were dissolved in chloroform:methanol (2:1, vol:vol) mixture and
the desired composition was dried under vacuum for 3 h to form a lipid film. The
buffer with or without 50 mM calcein was applied to the film and extensively
vortexed with glass beads until all of the lipids were resuspended, forming
multilamellar structures. The so-obtained suspensionwas extruded through 100 nm
membranes (Avestin, Canada) to form large unilamellar vesicles (LUV) of defined
size of approximately 100 nm. In the case of calcein containing vesicles, they were
further applied to a small Sephadex G-50 column to separate untrapped calcein
from the vesicles. The indicated lipid ratios are always molar. The lipid
concentrations were determined by enzymatic tests for lipid concentration
determination Phospholipids B (for choline containing DOPC and SM) and free
cholesterol C (for cholesterol) (both fromWako, Germany). The size of the LUVin
the absence or presence of various MBCD concentrations was determined by the
dynamic light scattering using Zeta Sizer 3000 (Malvern Instruments Ltd.).
2.3. Preparation of erythrocyte ghosts
Erythrocyte ghosts were prepared essentially as described in Bavdek et al. [34].
Briefly, fresh erythrocytes from healthy donor were washed in 130 mM NaCl,
20 mM Tris–HCl, pH 7.4 (erythrocyte buffer). Erythrocytes were lysed with five
volumes of cold 5mMNa2HPO4, pH 8.0. Lysed erythrocytes were centrifuged in a
benchtop centrifuge at 14,000×g and 4°C. Ghosts in the pellet were washed at the
same conditions until all of the hemoglobin was removed. The final pellet was
resuspended in a small volume of an SPR buffer. SM was depleted from
erythrocytes byB. cereus sphingomyelinase. One milliliter of washed erythrocytes
was incubated with 2 U/ml of B. cereus sphingomyelinase in erythrocyte buffer for
60 min at 37°C. Erythrocytes were washed well before use for ghost preparations.
The majority of SMwas removed from erythrocyte membranes according to TLC
and lipid concentration measurements (as described above).
2.4. Fluorescence measurements
Permeabilisation of calcein-loaded liposomes was measured by Jasco FP-
750 spectrofluorimeter. The excitation wavelength was 485 nm and the emission
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buffer was 20 μM. The permeabilisation induced by the MBCD was expressed
as the percentage of the maximal permeabilisation obtained at the end of the
assay by the addition of detergent Triton X-100 to a final concentration of 2 mM.
For the fluorescence scattering the excitation and emission wavelengths were
400 nm. The liposomes at 20 μM lipid concentration were stirred in the cuvette
and then MBCD in the buffer was added to rich the desired final concentration.
2.5. Fluorescence microscopy
NBD-CHO fluorescence on the L1 chip was imaged with the AxioImager Z1
microscope (Carl Zeiss, Germany) with a 10× objective using blue light
excitation (450–490 nm bandpass excitation and 515 nm longpass emission
filter). Fluorescence images were acquired with AxioCam MRm digital camera
and AxioVision 4.5 software (Carl Zeiss Vision, Germany) and further
processed in ImageJ 1.34 [35]. Images used for semi-quantitative comparison
of gray value profiles were acquired with the same microscope and camera
settings. Uneven background in the image was corrected with the Shading
Corrector plug-in in ImageJ using the image of an empty field on the chip
showing background fluorescence. On each of these corrected images the profile
of gray values was measured in a selected area, covering approximately 50% of
the image. Profiles were measured in the direction perpendicular to the flow cell
on the L1 chip. The profile values represent the average fluorescence intensity in
the vertical pixel lines of the profile area.
2.6. Surface plasmon resonance (SPR)
Biacore X system and L1 chip (both Biacore, Sweden) were used to monitor
cholesterol depletion from the chip immobilized LUV. The 100 nm LUV were
immobilized on the surface of the chip as described previously [33]. Initially, the
sensor chip surface was cleaned with three consecutive injections of 50 mM
NaOH: isopropanol 3:2 (vol:vol). LUV at 0.5–2 mM concentration were
injected at the flow rate 1 μl/min until the signal reached approximately 10000
response units (RU). Unbound vesicles were washed off the surface by two
consecutive 1-min injections of 100 mM NaOH at a flow rate of 30 μl/min flow.
The cholesterol depletion was performed at 25°C by injecting the desired
concentration of MBCD in the buffer for 30 min at 2 μl/min. MBCD binding to
clean L1 chip and CM5 chip was performed at 40 μl/min. The carboxylic groups
of CM5 chip were activated with the mixture of ethyl-N-(3-diethylaminopropyl)
carbodiimide and N-hydroxysuccinimide and blocked with ethanolamine
according to the producer's instructions (Biacore AB).
2.7. Data analysis
The raw sensorgrams were first normalized to 10000 RU of deposited LUV.
Then they were corrected with sensorgrams that were obtained by using
liposomes of the same DOPC:SM ratios, but without CHO, to account for the
decrease in the signal due to competition of MBCD for the lipophilic anchors of
the L1 chip (see the Results section). So corrected sensorgrams were fitted to a
bi-exponential decay model by using Origin software:
RðRUÞ ¼ Rfin þ A1ðexpk1 tÞ þ A2ðexpk2 tÞ
where Rfin represents the final response, A1 and A2 are amplitudes of each step
and k1 and k2 are apparent rate constants. For liposomes without SM, the second
term was not used and the data were reliably fitted to a mono-exponential decay
function. The linearization of the data was performed as described [36,37].
3. Results
3.1. Interaction of MBCD with DOPC membranes
In this paper we have used SPR approach to study the
MBCD extraction of CHO from the lipid membranes. LUV
were deposited on the surface of an L1 sensor chip, which
contains lipophilic anchors used for immobilization. Suchliposome-coated sensor chip is stable for hours and can be tested
for the binding of various compounds, i.e. proteins or lipids
[31]. In our case, MBCD solution was flowed across such a
surface at low flow-rate during so-called association phase,
when the ligand immobilized on the surface of the chip is in the
contact with the analyte, which is flown across. We have always
deposited approximately 10000 RU of LUV, which results in a
homogeneously covered sensor chip [33]. In such a system, the
increase or the decrease in the signal is linearly proportional to
changes of the amount of the material on the surface of the
sensor chip, respectively [31].
We have first checked whether MBCD itself interacts with
membranes without CHO, i.e. with liposomes composed of pure
DOPC. Awide concentration range of MBCD was tested, from
2 μM to 8 mM, but no interaction of MBCD with chip-
immobilized liposomes was observed at any concentration
(Fig. 1A). Instead, a small decrease of the signal was visible
during the association phase (Fig. 1A, inset). This decrease was
more pronounced at MBCD concentrations above 1 mM that are
typically used in cell biology research. The decrease was
significant at 4 and 8mMMBCD, where approximately 400 and
1000 RU of material was desorbed from the chip during the
association phase (Fig. 1A). These two concentrations were,
therefore, not used in any of the subsequent experiments. The
decrease of the signal during the association phase could be
either due to extraction of DOPC by MBCD or due to com-
petition of MBCD with chip-attached liposomes for the binding
to lipophilic anchors of L1 sensor-chip. Lipophilic anchors could
in principle be accommodated in theMBCDhydrophobic cavity.
We have tested for these possibilities by checking the binding of
MBCD to L1 chip alone (Fig. 1B) and compared it to the binding
to CM5 chip, with blocked carboxylic functional groups, which
do not posses lipophilic anchors (Fig. 1C). The binding was
better on L1 chip (Fig. 1D), indicating for an interaction of
MBCDwith lipophilic anchors. This interaction is, however, not
tight as the signal decreases to initial values immediately. At
high MBCD concentrations the signal at the beginning of the
dissociation phase is below the signal before the injection. This
is most likely due to matrix effects, i.e. dextran matrix on the
surface of the chip accommodates to different buffer conditions
but after some time reaches the initial value (as seen in Fig. 1C).
To further test that MBCD does not interact with DOPC
liposomes, we have also checked effects of MBCD on the size
and permeability of liposomes composed of DOPC and DOPC
containing 40 mol% of CHO. The presence of MBCD did not
affect the size of DOPC liposomes, i.e. the dimensions de-
termined by the dynamic light scattering were 122±1 nm in the
absence of MBCD and 122±2 in the presence of 2 mMMBCD.
MBCD reduced the diameter of DOPC:CHO 60:40 liposomes
by approximately 5 nm, that is from 121±1 in the absence of
MBCD to 116±1 in the presence of 2 mM MBCD. This was
further confirmed by monitoring light scattering, where DOPC
liposomes were not affected by the presence of MBCD, while
DOPC:CHO 60:40 liposomes showed a decreased intensity of
scattered light, consistent with the reduction in the size of the
liposomes when MBCD was present (Fig. 2A and B). MBCD
does not affect the permeability of the membranes, as there
Fig. 1. Interaction of MBCD with DOPC liposomes. MBCD was dissolved in the SPR buffer (20 mM NaH2PO4, 140 mMNaCl, 1 mM EDTA, pH 7.5.). The flow-rate
was 40 μl/min and experiments were performed at 25°C. The concentration (from bottom to top) were in all cases, 2 μM, 5 μM, 10 μM, 20 μM, 50 μM, 100 μM,
250 μM, 500 μM, 1 mM, 2 mM, 4 mM and 8 mM MBCD. (A) Binding of MBCD to DOPC liposomes. The L1 chip was covered with approximately 10000 RU of
DOPC liposomes prior to measurements. (B) Binding to L1 chip. (C) Binding to CM5 chip. CM5 chip was activated and then blocked by using standard reagents and
procedure recommended by the producer (Biacore). (D) The difference between the responses on L1 and CM5 blocked chips. The inset is showing the response values
at equilibrium, i.e. at the end of the association phase.
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somes tested (Fig. 2C and D). We have, however, observed
slight decrease of the fluorescence signal for calcein-loadedFig. 2. Effect of MBCD on liposomes. The light scattering (A and B) and calcein flu
40 mol% of CHO (B and D). Liposomes at 20 μM concentration were stirred at 25°C
experiments. The excitation and emission wavelengths were 485 nm and 520 nm for
time 0 MBCD was added and fluorescence measured. The concentrations of MBCD
4 mM.DOPC:CHO 60:40 liposomes, which may be explained by
increased self-quenching of calcein due to the reduced volume of
liposomes.orescence (C and D) for DOPC liposomes (A and C) and DOPC liposomes with
. Excitation and emission wavelengths were set to 400 nm for the light scattering
calcein release experiments, respectively. Slits were in all cases set to 5 nm. At
were in all cases (from top to bottom) 0, 0.25 mM, 0.5 mM, 1 mM, 2 mM and
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affected by the concentrations of MBCD tested, i.e. MBCD
does not extract DOPC molecules from the liposomes in this
concentration range. The decrease of the SPR signal in the
presence of high concentrations of MBCD is, therefore, due to
competition of MBCD and immobilized liposomes for the
binding to lipophilic anchors of L1 chip. So we had always
performed controls in the absence of CHO and used them to
correct the sensorgrams (see below).
3.2. Selective extraction of CHO by MBCD
We have initially characterized the selective extraction of
CHO from DOPC liposomes. Conditions, used also in further
experiments, were chosen to mimic the MBCD extraction
protocols used by researchers in cell biology. The MBCD was
injected across the liposome-covered surface of L1 chip at a very
low flow rate of 2 μl/min (Fig. 3, arrow). Injection of MBCD
caused a large decrease in the signal when DOPC:CHO 60:40
liposomes were used. To check for the selective extraction of
CHOwe have probed surface of the chip after CHO depletion for
the binding of streptolysin (Fig. 3, point a), a CHO dependent
pore forming toxin [38]. Streptolysin requires CHO for stable
binding and does not bind to membranes in the absence of CHO.
Streptolysin did not bind to such a surface (Fig. 3, trace a),
however, it bound significantly to the surface that contained the
same RU amount of DOPC:CHO 60:40 liposomes as depleted
liposomes (point b and trace b in the inset).
We have also used a fluorescent analogue of CHO (NBD-
CHO) to visualize the surface of the chip by fluorescence
microscopy (Fig. 4). The extraction of NBD-CHO by MBCD
(point c in Fig. 4, upper panel) efficiently removed NBD-CHOFig. 3. Selective extraction of cholesterol from membranes as evidenced by the
use of cholesterol dependent cytolysin. The liposomes composed of DOPC and
CHO at 40 mol% were immobilized on a clean L1 chip to approximately 10000
RU by using a low flow-rate 1 μl/min. Liposome surface was primed two times
by 100 mMNaOH injections of 1 min at 30 μl/min (denoted by asterisks). At the
time, designated by an arrow, 1 mM MBCD was injected at 2 μl/min. After the
depletion (point a) the surface was tested for the binding of cholesterol-dependent
cytolysin streptolysin (inset) at 30 μl/min. The association was 90 s and the
dissociation was followed for 5 min. The concentration of streptolysin was
approximately 10 μg/ml. The binding to cholesterol depleted surface (trace a in
inset) was compared to the binding to the surface that contains approximately the
same RU amount of original liposomes (dashed trace and trace b in the inset).
Fig. 4. Selective extraction of cholesterol from membranes as evidenced by the
use of fluorescently labelled cholesterol. In the upper panel, liposomes com-
posed of DOPC and NBD-CHO at 30 mol% were immobilized on a clean L1
chip as described in the legend to Fig. 3. The middle panel is showing the part of
the flow-cell imaged by fluorescence microscopy and the lower panel is showing
the profile of fluorescence intensity across the images in the middle panel.
(a) The fluorescence of a sensor chip before the deposition of liposomes; (b) the
fluorescence of a sensor chip when approximately 7400 RU of DOPC with
NBD-CHO were deposited; (c) the fluorescence of a sensor chip after NBD-
CHO depletion; (d) fluorescence intensity of a surface of a sensor chip after
deposition of DOPC:NBD-CHO liposomes to the level reached after CHO
depletion (i.e. point d).from DOPC:NBD-CHO 70:30 liposomes. Only 14% of the
fluorescence remained on the chip, compared to point b, which
represent 100%, i.e. the total amount of NBD-CHO before
the extraction. When approximately the same RU amount of
DOPC:NBD-CHO 70:30 was immobilized (point d), the sur-
face of the chip was brightly fluorescent and the amount of the
fluorescence approximately corresponds to the amount of fluo-
rescent NBD-CHO on the surface of the chip, i.e. approximately
6200 RU (point d) represents 84% of the response of point b
Fig. 5. Extraction of CHO from liposomes of various compositions. The liposome covered surface of L1 chip was prepared as described in the legend to Fig. 3. The
cholesterol was extracted with 0.25, 0.5, 1 and 2 mMMBCD (curves from top to bottom) at 2 μl/min for 30 min. (A) DOPC:SM:CHO 70:0:30; (B) DOPC:SM:CHO
53:17:30; (C) DOPC:SM:CHO 30:30:40; (D) DOPC:SM:CHO 40:40:20. The sensorgrams for DOPC:SM:CHO 17:53:30 looked similar to those presented in panel D.
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rescence (Fig. 4, middle panel).
These data collectively indicate that the signal decrease is
due to selective removal of CHO from the liposomes.
3.3. Extraction of CHO frommembranes of various composition
We have then performed the extraction of CHO with in-
creasing concentrations of MBCD frommembranes, where ratio
of DOPC, SM and CHO was varied (Figs. 5 and 6). The
extraction of CHO was rapid from DOPC liposomes in the
absence of SM. It was almost complete in 30 min even when the
lowest 0.25 mM concentration of MBCD was used (Fig. 5A).
The presence of SM slowed down the extraction to quite a
considerable level, and the final amount of extracted cholesterolFig. 6. Extraction of CHO from liposomes of various compositions. The amount of
extractedCHO from liposomes of various compositions after 30min depletion with
0.5 mM MBCD. Experimental conditions are the same as in Fig. 3. We have
assumed that only CHO was extracted with MBCD and that the contributions of
CHOandDOPC to the refractive index changewere similar. n=3–6, average±S.D.was also decreased (Fig. 6), as shown for DOPC:SM:CHO
53:17:30 (Fig. 5B) and DOPC:SM:CHO 30:30:40 (Fig. 5C).
The extraction of cholesterol was almost negligible for DOPC:
SM:CHO 40:40:20 (Fig. 5D), DOPC:SM:CHO 17:53:30, and
DOPC:SM:CHO 0:80:20 (Fig. 6) or other SM:CHO mixtures
(data not shown).We have also checkedwhether the temperature
affected the extraction of CHO from DOPC:SM:CHO 30:30:40
liposomes. Both the final amount of desorbed material and the
kinetics of the extraction were considerably changed when
extraction proceeded at 37°C (Fig. 6 and see below). We have
also observed that the stability of the liposomes attachment on
L1 chip was dependent on the presence of SM and may be
connected with the rigidity of the membrane. At high SM con-
centration in liposomes, controls were desorbed more than the
tested liposomes that contained also CHO, i.e. DOPC:SM:CHO
40:40:20, DOPC:SM:CHO 17:53:30, or any mixture of SM and
CHO. The resulting curves showed artifacts at the beginning of
the association phase (see the increase at the beginning of the
injection in the case of DOPC:SM:CHO 40:40:20 in Fig. 5D),
but anyway allowed a clear conclusion that the amount of
extracted CHO was none or extremely low for these mixtures.
These curves were not used for further analysis.
3.4. The kinetics of CHO extraction
The data for 0.5 and 2 mM MBCD of some of the tested
compositions were fitted to a mono- and bi-exponential model to
obtain the apparent rates of cholesterol extraction (Fig. 7). It
was possible to use mono-exponential curves to fit the data for
DOPC:CHO 70:30, yielding reasonably minor residuals
(Fig. 7A). The linear transformation of the response curves
Fig. 7. Fits to the experimental data. Experimental data for the extraction of CHO with 0.5 (squares) or 2 (circles) mMMBCD were fitted to a mono-exponential decay
(panel A) or bi-exponential decay (panels B–D). The plot on the right shows the linear transformation of the data on the left side. The transformed data of panel a were
fitted to a linear function (red line) and the derived rates, from the slopes of the curves, are reported together with other parameters in the Table 1. The residuals are also
shown for the fit to the mono-exponential decay (solid symbols) or bi-exponential decay (open symbols). (A) DOPC:SM:CHO 70:0:30; (B) DOPC:SM:CHO
53:17:30; (C) DOPC:SM:CHO 30:30:40; (D) DOPC:SM:CHO 30:30:40 when extraction was performed at 37°C.
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as the data for DOPC:CHO 70:30 yielded the linear relationship.
The derived parameters of the fits are reported in Table 1. The
apparent rates of extraction in the case of DOPC:CHO 70:30,
determined from the slopes of curves after linear transformation,Table 1
The kinetic parameters for the extraction of CHO with 0.5 or 2 mM MBCD derived
Lipid composition Fast
k t50 A
s−1×10−3 s RU
0.5 mM MBCD
DOPC:SM:CHO 70:0:30 2.8±0.9 271±83 1814±84
DOPC:SM:CHO 53:17:30 3.4±0.6 220±24 575±125
DOPC:SM:CHO 30:30:40 5.8±1.9 131±46 389±134
DOPC:SM:CHO 30:30:40 37°C 6.7±0.4 105±7 871±36
2 mM MBCD
DOPC:SM:CHO 70:0:30 20.9±2.1 33±4 1828±43
DOPC:SM:CHO 53:17:30 15.8±0.8 46±2 814±6
DOPC:SM:CHO 30:30:40 10.8±1.0 65±6 850±83
DOPC:SM:CHO 30:30:40 37°C 13.3±0 52±0 1797±16
n.d., not determined.
a Number of experiments.were similar to rates obtained by fitting the experimental data to
a mono-exponential curve. At 2 mM MBCD half of the cho-
lesterol was extracted in approximately 30 s. The kinetics of
extraction was more complex for compositions that contain SM
and fitting to mono-exponential curve produced poor fits andfrom the data presented in Fig. 7
Slow n a Linearisation n a
k t50 A k
s−1×10−3 s RU s−1×10−3
4 2.8±1.0 4
0.4±0.2 2276±797 1894±377 3 n.d.
0.9±0.3 832±310 1485±102 4 n.d.
1.1±0.02 648±17 1789±36 3 n.d.
3 22.4±2.5 3
3.7±0.3 192±6 982±10 4 n.d.
1.7±0.2 411±56 1456±77 6 n.d.
2.0±0.2 344±28 745±104 2 n.d.
Fig. 8. Extraction of CHO from erythrocyte ghosts. Erythrocyte ghosts were
prepared from human erythrocytes and immobilized on the surface of an L1
sensor chip to approximately 1000 RU. The depletion of cholesterol was
performed with 0.5 mM MBCD for 30 min at 25°C. The ghosts were prepared
from untreated erythrocytes (upper curve) or from SM-depleted erythrocytes
(lower curve). The curves are corrected for the contribution of MBCD to the
refractive index. The representative curves of five experiments from two
independent ghost preparations are shown. Inset: the amount of extracted
cholesterol after 30 min of depletion. n=5, average±S.D.
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(Fig. 7B–D and Table 1). The two phases had t50 of 46–65 s and
3–7 min, respectively, when 2 mM MBCD was used. We
performed extraction also at 37°C for the mixture DOPC:SM:
CHO 30:30:40. In comparison to 25°C the extraction was more
rapid and more CHO could be extracted when 0.5 mM MBCD
was used (Fig. 7C, D and Table 1).
3.5. The extraction of CHO from erythrocyte ghosts
Finally, we have checked the extraction of cholesterol from
human erythrocyte ghosts. Approximately 150 RU were ex-
tracted from untreated erythrocytes, when approximately 1000
RU of ghosts were immobilized on the surface of L1 chip
(Fig. 8). The experimental curves could be fitted to a bi-
exponential model with apparent rate constants of 0.035 s−1 and
1.2×10−3 s−1 for the fast and the slow step, respectively (data
for the curve in Fig. 8). The removal of SM from erythrocyte
membranes by bacterial sphingomyelinase resulted in the in-
crease of extracted cholesterol (Fig. 8), which is in the agree-
ment with the data obtained on liposomes.
4. Discussion
In this paper we have developed an SPR approach to monitor
the extraction of CHO by MBCD. The obvious advantage of
SPR approach in comparison to isothermal titration calorimetry
[11,27] and other approaches [4,5,8,17,18,26] is that it is
possible to obtain data in real time and without radioactive or
fluorescent labeling. The developed approach allowed us to test
the hypothesis that the slow pool of extracted cholesterol in cell
culture studies may be due to lateral segregation of lipids.
Our data indicate that MBCD does not partition in the DOPC
membrane (Fig. 1), does not change the size of the DOPC LUV
(Fig. 2), and neither perturbs membrane bilayer and induces
calcein release from liposomes (Fig. 2). When CHO was present
the vesicles shrank upon removal of CHO, but again without
any calcein release (Fig. 2). Eventual escape of calcein wastested by on-chip permeabilisation assay, when calcein loaded
vesicles immobilized on the surface of L1 chip were treated by
MBCD, buffer coming from the cell collected and checked for
the fluorescence [33]. In that case calcein release was always
less than 10% from calcein-loaded liposomes composed of
DOPC or DOPC:CHO 60:40, when up to 2 mM concentrations
of MBCD were used. Our data are thus in accordance with other
studies that showed no binding of MBCD to lipid membranes
[1,4] and no appreciable extraction of other lipids [10,11,27].
The removal of CHO from mixed DOPC:CHO membranes
was fast, and proceeded in seconds when mM concentrations of
MBCD were used. According to experiment with cholesterol-
dependent cytolysin streptolysin and fluorescent CHO ana-
logue, NBD-CHO, it was also complete. The extraction of
NBD-CHO was extremely rapid, as the majority of NBD-CHO
present in liposomes was extracted in approximately 2 min. It is
interesting to note that a bulky fluorophore group attached to the
isoalkyl chain of CHO did not affect much the interaction with
MBCD. It seems that the main interaction of CHO with MBCD
is mediated by the steroid ring system. As we could observe
hardly any fluorescence after the extraction, i.e. only 14% of
NBD-fluorescence remained (Fig. 4), clearly both monolayers
were depleted of NBD-CHO, indicating that the flip-flop
diffusion for this particular lipid occurs within 1 min. When
CHO was used in DOPC liposomes we could extract almost
complete CHO in less than 2 min with 2 mMMBCD, i.e. the t50
was 33 s (Fig. 5 and Table 1). The observed decrease in re-
sponse signal approximately corresponds to the amount of CHO
present in lipid membranes (we have assumed that the
contributions of CHO and DOPC to the refractive index change
were similar). Hence, from the described results we could
estimate that the CHO flip-flop diffusion in DOPC mem-
branes is completed in less than 1 min. This estimate is similar
to those of other authors who used MBCD; they have also
estimated the half times for interbilayer cholesterol flip-flop
movement to less than 1–2 min [10], while Steck and co-
workers have it estimated to be less than 1 s when using MBCD
[8]. In either case, the cholesterol flip-flop diffusion seems to
be a relatively fast and not rate-limiting process, and thus does
not influence significantly the rate of cholesterol extraction
from membranes [10].
The presence of SM drastically slowed down the extraction of
CHO from liposomes (Fig. 5) and erythrocyte ghosts (Fig. 8), in
accordance with the notion that the CHO efflux from cellular and
model membranes is slower in the presence of SM [17,19–22].
The bi-exponential kinetics was used to evaluate the data for
mixtures DOPC:SM:CHO 53:17:30 and DOPC:SM:CHO
30:30:40. The two phases could conceptually correspond to
the existence of two CHO populations, one that is associated
with SM and another that is not. The CHO population not
associated with SM should be extracted rapidly, and indeed, the
t50 roughly corresponds to that for CHO extracted from DOPC
liposomes. The t50 for the other CHO fraction was from approx-
imately 3 to 7 min. The relative amount of each population
depended on the amount of SM in the liposomes. In DOPC:SM:
CHO 53:17:30 mixture both populations were equally repre-
sented, as the RU amplitudes were similar when CHO was
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30:30:40, more CHO was associated with SM and this was
reflected in the amplitude of the slow phase, which was almost
twice as big as the amplitude of the fast phase. When the
extraction of CHO from this mixture was performed at 37°C, the
ratio actually reversed and more CHO was extracted during the
fast phase, since the membrane was more fluid and CHO was
less tightly associated with SM. Our study also suggests that
liquid-ordered and liquid-disordered lipid domains, resulting on
de-mixing of CHO and SM combined with phosphatidylcholine,
account for differential CHO extraction by MBCD. One reason
for the slower depletion of CHO from liquid ordered phases,
typical for SM:CHO mixtures, may be a higher affinity of CHO
for SM than for phosphatidylcholine [39]. However, another
possibility could not be excluded at present. Namely, as com-
pared to DOPC headgroup that of SM may be oriented differ-
ently, thus hindering CHO in an umbrella-like manner from the
MBCD accession [40].
We have performed experiments at 25°C and by using lower
concentrations of MBCD (up to 2 mM). In cell biology, a CHO-
depletion experiment is usually performed at 37°C, with higher
MBCD concentrations (not uncommon up to 10 mM) and even
by using other CD. Despite of this, our data clearly indicate that
the kinetics of CHO extraction byMBCD from lipid membranes
of composition that favors formation of lipid domains is com-
plex and indicate that the complex kinetics observed in experi-
ments with cells may be the consequence of lateral segregation
of lipids and CHO interaction with SM [4,5,17,18]. As seen in
Table 1, less CHO was associated with the fast pool if a higher
amount of SM was used. In some cases, even no extraction of
CHOwas observed (Fig. 6), indicating that CHO associated with
SM is harder to extract then CHO associated with DOPC. This
suggests that one should take extra care when performing the
MBCD extraction on cells. It is quite possible that only CHO in
lipid disordered domains, i.e. associated with unsaturated lipids
in cell membrane, would be preferentially extracted, if low
MBCD concentration or short extraction times are used.
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